Non-Conventional Pain Management for Sickle Cell Disease
نویسندگان
چکیده
منابع مشابه
Update on pain management in sickle cell disease.
Acute pain is the hallmark of sickle cell disease and is the most common cause of hospital admissions. Tissue damage due to vaso-occlusion releases numerous inflammatory mediators that initiate the transmission of painful stimuli that culminate in the perception of pain. The acute sickle cell painful crisis evolves along four phases. Each phase is coupled with changes in certain markers of the ...
متن کاملPain Management in Patients with Sickle Cell Disease - a Review
Pain is defined, by the International Association for the Study of Pain (IASP), as an ‘unpleasant sensitive and emotional experience, associated with or described in terms of tissue lesion’. It may be classified as acute or chronic when it becomes a symptom that worsens the quality of life, and thus loses its protective function. Pain may also be considered as chronic when it lasts over 3 to 6 ...
متن کاملNeonatal Screening for Sickle Cell Disease in Southwest Iran
the risk of sickle cell complications that is a common hemoglobin disorder in Southwest Iran. This study aimed at determining the incidence of Sickle Cell Disease (SCD) and other Hemoglobinopathies in newborn being at risk based on ethnic origin. Materials and Methods: In this descriptive epidemiologic study, between September 2013 and September 2015, 8363 newborn blood samples were test...
متن کاملSickle cell disease pain management in adolescents: a literature review.
Sickle cell disease (SCD) pain continues to emerge in adolescents. More than 98,000 individuals are believed to have SCD in the United States. In fact, 1 in 500 Black infants will be affected by SCD. Identifying standards of care for this unique population can improve pain management and treatment. A significant effect of vaso-occlusive crisis is a decrease in the quality of life in children. T...
متن کاملManagement of sickle-cell disease.
The two most controversial aspects of the management of sickle-cell disease are first, the treatment of the painful, vasoocclusive crisis and second, the value of community screening programmes. The controversy over treatment of the painful crisis has followed the promotion of urea as a clinically effective anti-sickling agent (Nalbandian, Shultz, Lusher, Anderson, and Henry, 1971; McCurdy and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Hematology & Oncology
سال: 2017
ISSN: 2375-7965
DOI: 10.26420/annhematoloncol.2017.1161